Vimarsana.com
7
8
9
10
11
12
13
Latest Breaking News On - Steven seedhouse - Page 6 : vimarsana.com
FDA staff unsure NASH drug's 'modest' benefits outweigh safety risks
BioPharma
United-states
Americans
Brian-skorney
Steven-seedhouse
Michael-yee
Raymond-james
Madrigal-pharmaceuticals
Intercept-pharmaceuticals
Drug-administration
Viking-therapeutics
Akero-therapeutics
Fda
Apellis reports strong start for new vision loss drug
BioPharma
Raymond-james
Jon-miller
Iveric-bio
Steven-seedhouse
Astellas-pharma
Drug-administration
Dive-brief
Apellis-pharmaceutical
Wall-street
Umer-raffat
Biotech
Why InflaRx Stock Skyrocketed This Week
The biopharmaceutical company's near-term sales outlook has gotten a huge boost following Emergency Use Authorization for one of its drugs.
Germany
German
Guggenheim-yatin-suneja
Raymond-james
Inflarx-gohibic
Steven-seedhouse
Drug-administration
Emergency-use-authorization
Yatin-suneja
StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy
Nine analysts raise stock price targets for Apellis Pharmaceuticals after it wins the FDA's first approval for a geographic atrophy therapy.
Peter-stein
Raymond-james
Iveric-bio
Annabel-samimy
Steven-seedhouse
Yigal-nochomovitz
Robertw-baird
Laura-chico
Chris-howerton
Chirinjeev-kathuria
Doug-tsao
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full-year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Greg-zante
Gregory-zante
Steven-seedhouse
Raymond-james
Joon-lee
Stephanie-diaz
Exchange-commission
Meeting-of-the-obesity-society
Therapeutics-inc
Nasdaq
Viking-therapeutics
vimarsana © 2020. All Rights Reserved.